Abbvie (ABBV) exec says there will be some erosion from Imbruvica due to competition and price negotiation, via JPM Conference
Importance
Level 1
#ABBVIE INC#ABBV.US#JPMORGAN CHASE & CO#EQUITIES#EU SESSION#US SESSION#BIOTECHNOLOGY#DIVERSIFIED BANKS#BIOTECHNOLOGY (GROUP)#BANKS#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BANKS (GROUP)#S&P 500 INDEX#ABBVIE INC#ABBV#JPM#GLOBAL NEWS